BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2002
View Archived Issues
Drug pipeline for anxiety
Read More
Thalidomide plus temozolomide in malignant gliomas
Read More
Good tolerability profile reported for tetracycline COL-3 in high-grade glioma
Read More
EMD-121794 reported to be well tolerated in patients with malignant gliomas
Read More
Enzyme-inducing anticonvulsants improve tolerability of CCI-779 in patients with CNS tumors
Read More
Improved tolerability of PZA in glioblastoma multiforme patients receiving anticonvulsants
Read More
Tolerability of intratumoral DTI-015 in recurrent malignant glioma
Read More
T-138067 inactive in astrocytoma and glioblastoma multiforme
Read More
Promising data reported for dendritic cell vaccine in GBM
Read More
Boston Scientific acquires Smart Therapeutics
Read More
Bayer describes inhibitors of PDE7B for asthma and bone disorders
Read More
Novel nicotinic acetylcholine and/or 5-HT receptor ligands covered by Merck patent
Read More
Two series of cytokine production inhibitors with utility in arthritis and heart failure
Read More
New CRF antagonists under study at GSK
Read More
BMS designs new series of PDE7 inhibitors
Read More
Sankyo scientists prepare benzopyran compounds with multiple mechanisms of action
Read More
Senju claims novel compounds with potential in reflux esophagitis
Read More
Encouraging results from phase II trial with IP-751 in neuropathic pain
Read More
Solvay acquires exclusive worldwide rights to cetrorelix
Read More
Preclinical efficacy of Cerebragel in brain cancer
Read More
Organon and Entelos expand research collaboration
Read More
FDA approves Pegasys and Copegus combination therapy in hepatitis C
Read More
Swissmedic approves Glivec for first-line treatment of CML
Read More
Celltech returns rights to CF program to Targeted Genetics
Read More
Allos to begin rolling NDA submission for RSR-13
Read More
